(Q39121751)

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

9 September 2017

2 references

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

title

MicroRNA-126 inhibits osteosarcoma cells proliferation by targeting Sirt1. (English)

1 reference

9 September 2017

1 reference

Jian-Qiang Xu

1

1 reference

9 September 2017

Ping Liu

series ordinal

2

1 reference

9 September 2017

Ming-Jue Si

series ordinal

3

1 reference

9 September 2017

Xiao-Yi Ding

series ordinal

4

1 reference

9 September 2017

publication date

24 July 2013

1 reference

9 September 2017

1 reference

9 September 2017

volume

34

1 reference

9 September 2017

issue

6

1 reference

9 September 2017

page(s)

3871-3877

1 reference

Osteosarcoma: anatomic and histologic variants

9 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0974-X

Osteosarcoma: Conventional treatment vs. gene therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0974-X

MicroRNAs: genomics, biogenesis, mechanism, and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0974-X

The evolution of gene regulation by transcription factors and microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0974-X

Oncomirs - microRNAs with a role in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0974-X

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0974-X

Functional elucidation of MiR-34 in osteosarcoma cells and primary tumor samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0974-X

Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0974-X

MicroRNA-221 induces cell survival and cisplatin resistance through PI3K/Akt pathway in human osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0974-X

Heat shock protein 90B1 plays an oncogenic role and is a target of microRNA-223 in human osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0974-X

let-7b and miR-126 are down-regulated in tumor tissue and correlate with microvessel density and survival outcomes in non--small--cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0974-X

miR-126 and miR-126* repress recruitment of mesenchymal stem cells and inflammatory monocytes to inhibit breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0974-X

MiR-126 suppresses colon cancer cell proliferation and invasion via inhibiting RhoA/ROCK signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0974-X

hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0974-X

Mammalian SIRT1 represses forkhead transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0974-X

Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0974-X

SIRT1 functionally interacts with the metabolic regulator and transcriptional coactivator PGC-1{alpha}

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0974-X

PPARα-Sirt1 complex mediates cardiac hypertrophy and failure through suppression of the ERR transcriptional pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0974-X

FXR acetylation is normally dynamically regulated by p300 and SIRT1 but constitutively elevated in metabolic disease states

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0974-X

How does SIRT1 affect metabolism, senescence and cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0974-X

SIRT1 is significantly elevated in mouse and human prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0974-X

DBC1 is a negative regulator of SIRT1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0974-X

SIRT1 is essential for oncogenic signaling by estrogen/estrogen receptor α in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0974-X

Antitumor effect of SIRT1 inhibition in human HCC tumor models in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0974-X

Resveratrol inhibits proliferation and promotes apoptosis of osteosarcoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0974-X

Interplay among BRCA1, SIRT1, and Survivin during BRCA1-associated tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0974-X

The SIRT1 deacetylase suppresses intestinal tumorigenesis and colon cancer growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0974-X

microRNA-195 suppresses osteosarcoma cell invasion and migration in vitro by targeting FASN.

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23877372

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

MicroRNA-21 is involved in osteosarcoma cell invasion and migration

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23877372

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S13277-013-0974-X

1 reference

9 September 2017

1 reference